Bayer's Perspective on Innovation 2008
At this year´s press conference on "Bayer´s Perspective on Innovation 2008", innovation champions of the Bayer group were in the focus. Werner Wenning (Chairman of the Board of Management of Bayer AG) and Dr. Wolfgang Plischke (member of the Board of Management of Bayer AG, responsible for innovation, technology and environment) presented the work in research and development at Bayer HealthCare, Bayer Crop Science and Bayer Material Science
Press release
Fact sheets divisions
| Fact Sheets | PDF for Download |
|---|---|
|
Animal Health
Management of age-related diseases in pets |
|
|
Cardiology
Cinaciguat (sGC activator) - a promising compound for the treatment of acute decompensated heart failure |
|
|
Cardiology
Riociguat (sGC stimulator) - a promising treatment option against several forms of pulmonary hypertension |
|
|
Hematology
Xarelto - Innovation in the prevention of blood clots |
|
|
Molecular Imaging
Detect diseases before they show clinical symptoms |
|
|
Women's Healthcare
Innovation in Contraception |
|
